1 completed, 1 unknown, 1 withdrawn. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow sodium selenite pentahydrate: new trials by email Literature Review of sodium selenite pentahydrate trials Research Report on sodium selenite pentahydrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone Abiraterone Acetate, Sodium Selenite, Prednisone - Prostate Cancer, Castrate Resistant Prostate Cancer | Phase 1 | Withdrawn | Stanford University | 2020-10-01 | 2021-08-12 | |
| High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy sodium selenite pentahydrate, Normal saline, Chemotherapy - Chemotherapy-induced Peripheral Neuropathy, Recurrent Ovarian Carcinoma | Phase 3 | Unknown | Seoul National University Hospital | 68 | 2019-12-24 | 2023-06-26 |
| Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis sodium selenite pentahydrate, placebo - continuous saline NaCl 50 ml - Severe Sepsis | Completed | Pavol Jozef Safarik University | 4 | 2013-12-01 | 2017-04-10 |
Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Peripheral Nervous System Diseases (1) · Prostatic Neoplasms (1) · Sepsis (1)
Pavol Jozef Safarik University (1) · Seoul National University Hospital (1) · Stanford University (1)
Slovakia (1) · South Korea (1)
Hee Seung Kim, MD/PhD (1) · Susan J Knox (1)
PMID 21121149, PMID 25020262, PMID 34132071, PMID 36827018, PMID 41630017